Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancerChelsea Jackson, David M. Berman, Lina Chen et al.|The Journal of Pathology Clinical Research|2021Cited by 23
Immunohistochemical Assays for Bladder Cancer Molecular Subtyping: Optimizing Parsimony and Performance of Lund Taxonomy ClassifiersCéline Hardy, Chelsea Jackson, David M. Berman et al.|Journal of Histochemistry & Cytochemistry|2022Cited by 17
Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sectionsMaisa Yoshimoto, Jeremy A. Squire, Olga Ludkovski et al.|Laboratory Investigation|2018Cited by 17
Abstract 63: Incorporation of flanking probes reduces truncation losses for fluorescence in situ hybridization analysis of recurrent genomic deletions in tumor sections.Maisa Yoshimoto, Jeremy A. Squire, Olga Ludkovski et al.|Cancer Research|2013Cited by 3
Correction to: Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sectionsMaisa Yoshimoto, Jeremy A. Squire, Olga Ludkovski et al.|Laboratory Investigation|2018Cited by 2